BUSINESS● LOWJul 30 · Jul 30, 2026, 10:33 AM
Regeneron Pharmaceuticals beats top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha Tech
Regeneron Pharmaceuticals exceeded both top-line and bottom-line estimates and provided an updated financial outlook for fiscal year 2026.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS12m agoBusiness inflation expectations decelerate in October: Atlanta FedSeeking Alpha TechBUSINESS12m agoU.S. stocks rise after SpaceX jumps on earnings beat; traders await key earningsSeeking Alpha Tech